Related Experiment Videos
Q10 therapy in patients with idiopathic Parkinson's disease
E Strijks1, H P Kremer, M W Horstink
1Department of Neurology, University Hospital Nijmegen, The Netherlands.
Molecular Aspects of Medicine
|January 1, 1997
Abstract:
A 3-month open-label trial was performed to evaluate the efficacy of 200 mg Q10 daily in 10 patients with Parkinson's disease. Motor performance was assessed with UPDRS and motor tests. There was no significant effect on the clinical ratings.